Heart dosimetric analysis of three types of cardiac toxicity in patients treated on dose-escalation trials for Stage III non-small-cell lung cancer.

@article{Wang2017HeartDA,
  title={Heart dosimetric analysis of three types of cardiac toxicity in patients treated on dose-escalation trials for Stage III non-small-cell lung cancer.},
  author={Kyle Wang and Kevin Alexander Pearlstein and Nicholas D Patchett and Allison M Deal and Panayiotis Mavroidis and Brian C Jensen and Matthew B. Lipner and Timothy M. Zagar and Yue Wang and Carrie B. Lee and Michael J. Eblan and Julian G. Rosenman and Mark A. Socinski and Thomas E. Stinchcombe and Lawrence B. Marks},
  journal={Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology},
  year={2017},
  volume={125 2},
  pages={
          293-300
        }
}
BACKGROUND AND PURPOSE To assess associations between radiation dose/volume parameters for cardiac subvolumes and different types of cardiac events in patients treated on radiation dose-escalation trials. MATERIAL AND METHODS Patients with Stage III non-small-cell lung cancer received dose-escalated radiation (median 74 Gy) using 3D-conformal radiotherapy… CONTINUE READING